Samrat Pharmachem Ltd Valuation

530125 · Healthcare · Current price

Full stock page
DocStoX fair value
Not published yet
No estimate for 530125 at this time
Current price
—
P/E ratio
—
P/B ratio
1.1x
Model it yourself — Earnings Yield Calculator
Opens pre-filled with Samrat Pharmachem Ltd's latest numbers.

Is Samrat Pharmachem Ltd undervalued?

We have not published a fair value estimate for Samrat Pharmachem Ltd yet. Our valuation engine covers the market in waves, and this company has not been through a run that met our publishing bar. Rather than show a second, inconsistent number here, we would rather show none. The ratios, peer comparison and methodology below are still based on Samrat Pharmachem Ltd's reported financials.

Valuation multiples

Samrat Pharmachem Ltd trades at a P/E of — and a P/B of 1.1x, with a dividend yield of 0.4%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.

How we estimate fair value

When we publish an estimate for Samrat Pharmachem Ltd, it will appear here with the full working: the models used and their weights, every assumption and its source, the confidence band, and what data was missing. That is the same methodology we apply to every company.

Read the full fair-value methodology

Understand the ratios

P/E RatioP/B RatioPEG RatioEarnings Yield

More on Samrat Pharmachem Ltd

Fair ValueIntrinsic ValueDCFFinancial RatiosPeers

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.